6Farias T P, Dias F L, Lima R A, et al. Progncxstie factors and outcome for nasopharyngeal carcinoma [ J ]. Arch Oto- laryngol Head Neck Surg, 2003, 129(7): 794.
7Lin J C, Jan J S, Hsu C Y, et al. Phase Ⅲ study of concur- rent chemo- radiotherapy versus radiotherapy alone for ad- vanced nasopharyngeal carcinoma ; positive effect on overalland progression-free survival[J]. J Clin Oncol, 2003, 21 (4) : 631.
2Winky WKF,Vincent WCW, Peter MLT. Dosimetric eval- uation of a three-phase adaptive radiotherapy for na- sopharyngeal carcinoma using helical tomotherapy [J]. Medical Dosimetry, 2012,37 ( 1 ) :92-97.
3Sammy CHC, Michael TCY,Dora LWK,et al. Sonographic appearance of parotid glands in patients treated with in- tensity-modulated radiotherapy or conventional radiothera py for nasopharyngeal carcinoma [J]. Ultrasound in Medicine & Biology ,2011,37(2) :220-230.
4Shiris WSK,Vincent WCW,Michael KMK,et al. Dosimet- ric comparison of intensity-modulated stereotactic radio- therapy with other stereotactic techniques for locally recur- rent nasopharyngeal carcinoma [J]. International Journal of Radiation Oncology B iology Physics, 2011,79 ( 1 ) :71-79.
5Cheng HC,Wu VW,Ngan RK,et al. A Prospective study on volumetric and dosimetric changes during intensity modulated radiotherapy for nasopharyngeal carcinoma pa- tients [J]. International Journal of Radiation Oncology Bi- ology Physics, 2011,81 (2 Supplement ) : S 17 $.
6Edmond HNP,Mike YTL,Peter CST,et al. Salivary Ep- stein-Barr virus DNA level in patients with nasopharyn- geal carcinoma following radiotherapy [J]. Oral Oncology,2011,47(9):879-882.
7Chen L,Liu LZ,Chen M,et al. Prognostic value of sub- classification using mri in the t4 classification nasopha- ryngeal carcinoma intensity-modulated radiotherapy treat- ment [J]. International Journal of Radiation Oncology Bi- ology Physics, 2012,84( 1 ) : 196-202.
